IPM Take
Europe has just done something important with pathogen genomics: it has stopped treating sequencing as an optional marker of a sophisticated laboratory and started treating it as part of the regulatory architecture of food safety.
The new requirement matters because sequencing alone does not prevent an outbreak. Its value comes when genomic information moves quickly enough between laboratories, food-safety authorities and public-health agencies to establish whether infections in different places have a common source. Europe has now put an obligation behind that information flow.
Executive Summary
Commission Implementing Regulation (EU) 2025/179 became applicable on 23 August 2026, introducing mandatory requirements for whole-genome sequencing during investigations of foodborne outbreaks involving Salmonella enterica, Listeria monocytogenes, Escherichia coli, Campylobacter jejuni and Campylobacter coli.
When those pathogens are associated or suspected to be associated with an outbreak, competent authorities must collect relevant isolates from food, animals, feed or the related environment and conduct WGS on at least one isolate of each relevant serovar, biotype or molecular type. Results and specified metadata must then be transmitted to EFSA without undue delay, allowing comparison with human genomic information held through the joint EFSA-ECDC One Health WGS system.
Why it matters
- Regulators: Genomic investigation is no longer dependent on whether an individual Member State decides that sequencing is worth doing; a common regulatory baseline now applies.
- Laboratories: Sequencing capacity, quality assurance and interoperable metadata have become elements of regulatory compliance rather than research infrastructure alone.
- Food businesses: When requested and where available, operators may have to provide pathogen isolates and their own sequencing results to competent authorities.
Foodborne outbreaks are often discovered in reverse. Patients become sick, laboratories identify a pathogen, epidemiologists notice a cluster, investigators interview cases and regulators then attempt to reconstruct a food supply chain that may stretch across several countries. By the time a connection becomes visible, the implicated ingredient may have been processed into multiple products, shipped through different distributors and consumed far from its point of origin.
Whole-genome sequencing has already changed that investigative model by giving authorities a far more precise way to compare pathogens. A bacterial isolate found in a patient can be genomically compared with isolates obtained from food, animals, feed or environmental samples, helping investigators decide whether geographically separated cases are probably part of the same event. What changed on 23 August is not the science but its institutional status.
The new EU framework requires Member States to conduct WGS on relevant isolates during outbreak investigations involving five major bacterial pathogens and transmit those results to EFSA without undue delay. The accompanying information is also important: sequence and sample identifiers, pathogen species, the type of food, animal, feed or environmental source, sampling date, country, relevant Rapid Alert System for Food and Feed references and the national outbreak identifier all form part of the required data package.
This is what One Health looks like when it becomes operational rather than rhetorical. A hospital laboratory sees the human consequence of an outbreak, while food-safety laboratories and regulatory authorities investigate the possible source. If those sectors cannot compare information rapidly, both can possess excellent data and still miss the connection that matters.
The regulation therefore attacks a problem that is as much administrative as scientific. Europe has had an EFSA-ECDC One Health WGS system since 2022, but a shared technological platform does not automatically guarantee that Member States generate comparable data or submit it quickly. The new obligation creates a much stronger expectation that sequencing and metadata flow will be part of routine outbreak investigation.
Implementation will now decide whether the regulation delivers what the legislation promises. Member States need accredited laboratories capable of performing the required sequencing, personnel able to interpret genomic relationships, and information systems that can submit structured data without creating another layer of administrative delay. Food businesses also need to understand their role, particularly where isolates or company-generated WGS data already exist and are requested by authorities.
There is a wider lesson here for infectious-disease policy. Precision public health is sometimes presented as something futuristic, built around predictive analytics and increasingly sophisticated models. In practice, some of its greatest value comes from something less glamorous: making sure that a pathogen found in one laboratory can be reliably compared with a pathogen found somewhere else, and that the relevant authorities can act on the result before more people become sick.
Europe has now made that expectation legally binding. The sequencing technology is ready. The implementation test starts now.
